Cannabis cultivator Hilltop Leaf received £2 million as part of a private investment to become one of the largest medical cannabis producers in the U.K., according to the Insider.
Hilltop Leaf founder Hamish Clegg noted how medicinal cannabis use is growing, but that the U.K. currently remains reliant on imports.
Founded in 2019, Hilltop Leaf aims to produce pharmaceutical-grade cannabis-based products for human medicinal use (CBPMs). It also has a research partnership with Nottingham Trent University, which specializes in clinical trials and testing.
The company plans to compete with suppliers in other countries such as Canada, Germany, and Israel.
In addition, the company has an 11,000 square-mile production facility and hopes to supply over 10% of the U.K. market.
Image By Hilltop Leaf Via the Insider UK
In 2018, Great Britain legalized the medicinal use of marijuana being used by more than 20,000 patients in the U.K. However, around 1.8 million people in the U.K. use ‘black market’ cannabis to treat medical conditions, per the Centre for Medicinal Cannabis.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo: Courtesy Of Matteo Paganelli On Unsplash
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
